unknown
Stage
About
ZalVac AB develops vaccines based on bacterial membrane vesicles to induce robust immunity against multiple strains of bacteria, translating academic research by Birgitta Henriques Normark and Staffan Normark into vaccine candidates.
Explore ZalVac's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.